ANTIFUNGAL TRIAZOLE ALCOHOLS - A COMPARATIVE-ANALYSIS OF STRUCTURE-ACTIVITY, STRUCTURE TERATOGENICITY AND STRUCTURE THERAPEUTIC INDEX RELATIONSHIPS USING THE MULTIPLE COMPUTER-AUTOMATED STRUCTURE EVALUATION (MULTI-CASE) METHODOLOGY

被引:27
作者
KLOPMAN, G
PTCHELINTSEV, D
机构
[1] Department of Chemistry, Case Western Reserve University, Cleveland, 44106-7078, OH
关键词
QSAR; CASE; ANTIMYCOTICS; AZOLES; TERATOGENICITY;
D O I
10.1007/BF00125508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
An increase in the opportunistic fungal infections necessitates a design of new more effective and safer antifungal agents. Triazole alcohols are effective antifungals, but have a risk of teratogenicity associated with them. Therefore, successful design of drugs from this class depends on understanding the structure-activity and structure-teratogenicity relationships in conjunction. To this end, we applied the Multiple Computer-Automated Structure Evaluation (Multi-CASE) methodology to a study of the relationships between the structures of 71 triazole alcohols and their in vitro antifungal activity, teratogenicity, and therapeutic index. For each end point, several relevant structural descriptors were identified. A comparative analysis of the Multi-CASE results indicates that cyano, methoxy groups. and ortho-difluorination on the aromatic ring decrease antifungal activity. but not the therapeutic index because of the concomitant negative contribution to teratogenicity. Metabolically deactivating para-substitution in the benzene ring is beneficial for the therapeutic index in agreement with the idea of metabolically induced teratogenicity. Fluorinated para-alkyl substituents are most preferable. The pattern of ortho-substitution in the benzene ring affects both antifungal and teratogenic activity. This suggests that the relative orientation of the benzene ring with respect to the rest of the molecule may play a modulating role. The Multi-CASE model could correctly predict, a priori, the teratogenicity and antifungal potency of SCH 39304 and ICI 156,066 and be used to optimize the structure and therapeutic index of the latter.
引用
收藏
页码:349 / 362
页数:14
相关论文
共 16 条
[1]
BECHTER R, 1988, REV IBER MICOLOG S1, V5
[2]
Flint O. P., 1990, Chemotherapy of fungal diseases., P231
[3]
FLINT OP, 1985, CONCEPTS TOXICOL, V3, P29
[4]
GRASSBERGER MA, 1988, REV IBER MICOLOG S1, V5
[5]
Graybill J. R., 1990, Chemotherapy of fungal diseases., P455
[6]
HECTOR RF, 1988, REV IBER MICOLOG S1, V5, P11
[7]
HOBBS MM, 1988, 28TH INT C ANT AG CH
[8]
PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS [J].
HUMPHREY, MJ ;
JEVONS, S ;
TARBIT, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :648-653
[10]
A HIERARCHICAL COMPUTER AUTOMATED STRUCTURE EVALUATION PROGRAM .1. [J].
KLOPMAN, G .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1992, 11 (02) :176-184